A case study demonstrates that affinity chromatography can offer efficiency and scalability for gene therapy manufacturing using viral vectors.
Stephen Soltys
Advertisement
Stephen Soltys is Senior Field Application Scientist for POROS and CaptureSelect chromatography products, Bioproduction at Thermo Fisher Scientific (NC, USA).
Articles by Stephen Soltys
Advertisement
Latest Updated Articles
Affinity Chromatography Accelerates Viral Vector Purification for Gene TherapiesPublished: September 15th 2017 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Regulatory Challenges for Global Manufacturing of Vaccines
2
EU Biopharma Strategy: Scaling Up to Tackle Funding Gaps and Drive Innovation
3
AI-Driven Organ-on-Chip Platforms Are Changing the Game in Bio/Pharma R&D
4
Advances in Continuous Manufacturing, Drug Delivery Lead CPHI Pharma Awards 2025
5
